If you are planning to attend a scientific conference, you might be feeling overwhelmed by the sheer amount of information about the abstracts, sessions, and poster presentations. ASCO’s annual meeting (this year’s hashtag is #ASCO21) is one of the biggest conferences for medical affairs and oncology professionals. In order to get the most out of your conference attendance, you will need to have a clear plan in place. Here are some best practices that can help you get ready to attend.
If you’re not sure how to get started with your conference preparations, LARVOL can help. Our social listening tool, VIEW, brings you the conversations that top oncologists are having on Twitter. In addition, the VIEW tool provides expert sentiment analysis that can help you in your conference planning needs.
In addition to regular Clubhouse chats, LARVOL hosts live, 30-minute panel interviews immediately following major oncology conferences, including #ASCO21. During the panels, KOLs and experts in the particular cancer type will discuss 2-3 abstracts, moderated by a LARVOL expert in cancer research. Register to attend panels for #ASCO21 here, or contact us for information about upcoming panels.
Our conference planners are spreadsheets compiled by our team of experts that outline all sessions and abstracts, identified diseases, products, and MOAs. You’ll even get follow-up coverage on Twitter discussions after the conference is over. Request your planner for #ASCO21 here and maximize your attendance!
79% had reduction in disease. ORR 31%. Many responses deepen over time.
Toxicity profile was in line with prior TIL/Lifileucel data. No surprises here. Median # doses of IL-2 was 6.
Absolutely agree!… this should be available to our melanoma patients ASAP!… and paves the way for smarter cellular therapies to be designed, studied, and eventually widely disseminated
Just before I start AM clinic at @cityofhopeoc, excited to share results from #COBALT_RCC, a P1 trial of @CRISPRTX#CTX130 in #kidneycancer in the @sitcancer#PressProgram. Will present more on Thurs 5:37p at #SITC22! Thx @neerajaiims@DrBenTran@HaanenJohn#SamerSrour& co-Is! t.co/aDnhG9n92A
@montypal@cityofhopeoc@CRISPRTX@sitcancer@neerajaiims@DrBenTran@HaanenJohn@DrChoueiri@TiansterZhang@tompowles1@brian_rini@AlbigesL@Uromigos@ERPlimackMD@drenriquegrande@PGrivasMDPhD Congrats Monty! Looking forward to hearing about this exciting first-in the field study!
CAR-Ts are coming for #kidneycancer!! Congratulations @montypal and team; can’t wait to see results at #SITC22! t.co/9MrlF2yzBe
Congrats @montypal and team! Great to see CAR T therapy coming to #RCCt.co/ypRHBC89Pt
Another huge step from none other than @montypal!! CAR-Ts in #kidneycancer!Congratulations to the entire team!Looking forward to seeing the results at #SITC22! t.co/HvKeVBPyV7
@montypal you never stop to amaze me! You are brilliant & awesome! Looking forward to hearing more about this trial @sitcancer@OncoAlert@CityofHope_GU@COHMDCareers@neerajaiims@KidneyCancer@KidneyCancerDoc@NazliDizman@ZeynepZengin@LuisMezaco@crisbergerot@PauloBergerott.co/RNzOwxixQm